奈达铂联合紫杉醇治疗食管癌疗效评价_紫杉醇和奈达铂方案 【中图分类号】【文献标识码】A【文章编号】1005-2720(2021)05-0193-01 【【摘要】：^p 】目的：比较奈达铂 奈达铂联合紫杉醇治疗食管癌疗效评价_紫杉醇和奈达铂方案 【中图分类号】【文献标识码】A【文章编号】1005-2720(2021)05-0193-01 【【摘要】：^p 】目的：比较奈达铂、顺铂分别联合紫杉醇治疗食管癌疗效及毒副反应。方法：将食管癌病人随机分两组：分别用奈达铂+紫杉醇、顺铂+紫杉醇治疗。结果：两组疗效相当，但奈达铂组血液毒性较顺铂组重，胃肠道反应、肝、肾毒性较顺铂组轻。结论：奈达铂+紫杉醇治疗食管癌副反应轻，值得临床推广。 【【关键词】：^p 】奈达铂；顺铂；紫杉醇；食管癌 Evaluation the efficay of nedaplatin plus padita____el in patients with esophageal Jun.(The first people’s hospital of Hengyang，Hunan 421002 China) 【Abstract】Objective：To evaluate the efficacy and safety of paclita____el bined with nedaplatin or cisplatin in patients with esophageal ：The patients with esophageal cancer were randomized into two groups and each group was treated with Nedaplatin plus paclita____el or cisplatin plus paclita____el ：The efficacy of two groups was improverd，but the blood to____icity was serious in Nedaplatin group than in cisplatin group，and the gastointestinal reaction，the liver and kidney to____icity were lower in Nedaplatin group than in cisplatin ：Nedaplatin plus paclita____el was safe in treatment of esophageal cancer，worthy to be popularized.
【Key Words】Nedaplatin；Cisplatin；Paclita____el；Esophageal cancer 1 对象和方法 研究对象：50例均为术后病理证实为食
